Final multivariable random effects model of clinical associations of MetS over time
| Variable | Adjusted OR | 95% CI |
|---|---|---|
| MetS at previous visit (y/n) | 14.9 | 10.7 to 20.8 |
| Renal disease at baseline (y/n) | 1.53 | 1.01 to 2.3 |
| Antimalarial over time (y/n) | 0.67 | 0.47 to 0.95 |
| SLICC/ACR-DI>1 over time (y/n) | 2.37 | 1.64 to 3.42 |
| SLEDAI over time (per unit increase) | 1.07 | 1.02 to 1.13 |
| Age (years) | 1.04 | 1.03 to 1.05 |
| Hispanic | 2.25 | 1.28 to 3.96 |
| African ancestry | 3.35 | 1.59 to 7.01 |
MetS, metabolic syndrome; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; SLICC/ACR-DI, Systemic Lupus Erythematosus International Collaborating Clinics/American College of Rheumatology Damage Index.